Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion

NCT01534962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Atrial Fibrillation

Interventions

DRUG: Ranolazine
DRUG: Ranolazine
DRUG: Ranolazine
DRUG: Placebo

Sponsor

Menarini Group